Subscribe
24 Oct 2024 11:22 AM
In conversation with Bhavna Kewalramani, Sanofi India and Atul Suri, Alembic Pharmaceuticals.
11 Feb 2025 1:10 PM
11 Feb 2025 1:04 PM
11 Feb 2025 11:25 AM
11 Feb 2025 11:22 AM
10 Feb 2025 11:18 AM
10 Feb 2025 10:36 AM
06 Feb 2025 10:14 AM
03 Feb 2025 11:05 AM